Group Sustainable Development Policy
PDF | 161.48 KB
The rapidly changing healthcare environment offers an abundance of opportunities for companies that are poised and ready to adapt to evolving regulatory requirements and unique client needs. Seizing opportunities should be done in a sustainable and responsible manner to ensure that Mediclinic, as a good corporate citizen, is in the long term able to maintain its positive impact not only on its clients, but also on the industry, the planet, and on its employees, partners and surrounding communities.
Mediclinic’s track record on delivering growth and creating long-term value in across its divisions in Switzerland, Southern Africa and the United Arab Emirates is testament to its strategy of being a long-term player and delivering a sustainable business. While growth, profitability and creating shareholder value are certainly major strategic drivers, this cannot be achieved unless the Group offers efficient, effective, appropriate and evidence-based clinical services to its patients; follows ethical business practices; values its employees by following fair labour practices and offering competitive remuneration, training and development opportunities; respects the communities within which the Group operates and contributes to the well-being of society; and carefully manages its impact on the environment by focusing on its carbon footprint, use of energy and water resources and waste management.
Through the Group’s sustainability efforts Mediclinic believes that it will:
The Group Sustainable Development Policy, Group Environmental Policy and Code of Business Conduct and Ethics, which are reviewed annually, codify Mediclinic’s commitment to conducting business responsibly.
The following material sustainability issues have been identified and are addressed in the sustainable development report published annually and available below: (a) Developing an engaged and productive workforce; (b) Minimising environmental impacts; and (c) Being an ethical and responsible corporate citizen.
Reports on the Group’s sustainable development and corporate social responsibility are published annually with the annual report. Please visit the Investor Relations section for the latest and previous reports.
The Group’s division in South Africa, Mediclinic Southern Africa, forms an integral part of the political, social and economic community in South Africa and is committed to sustainable transformation as part of its business strategy. Mediclinic Southern Africa’s executive committee is responsible for ensuring that the appropriate focus is placed on the division’s commitment to the development and implementation of sustainable broad-based black economic empowerment (“B-BBEE”) initiatives.
Mediclinic does not tolerate any form of human rights violation and is committed to ensuring that no form of slavery or human trafficking occurs in human resources, the supply chain or in any other part of the business.
For each financial year, the Board issues a statement in terms of Section 54 of the United Kingdom Modern Slavery Act 2015, reporting on the steps taken during the year to prevent modern slavery in the workplace.
We value your opinion and invite you to complete a feedback survey on Mediclinic's sustainable development reports and initiatives. Please download the form below and submit it by any of the means indicated on the form.